论文部分内容阅读
目的:分析静脉溶栓治疗早期急性心肌梗死的临床疗效。方法:选取86例早期急性心肌梗死患者,根据是否采取静脉溶栓治疗进行分组;对照组41例,采取常规治疗,不给予静脉溶栓治疗;观察组45例,在对照组治疗的基础上,采取静脉溶栓治疗;对比两组患者的血管再灌注成功率、再通时间、ST-T段回落≥50%时间、住院时间及急性期心脏事件发生率。结果:观察组患者的血管再灌注成功率大于对照组,再通时间、ST-T段回落≥50%时间、住院时间均短于对照组,差异具有统计学意义(P<0.05);观察组急性期心脏事件发生率为17.78%,对照组急性期心脏事件发生率为36.59%,经χ2检验,观察组急性期心脏事件发生率显著小于对照组,差异具有统计学意义(P<0.05)。结论:静脉溶栓治疗早期急性心肌梗死的临床疗效确切,可显著缓解并控制病情,减少急性期心脏事件发生,且安全性高,具有临床可行性。
Objective: To analyze the clinical effect of intravenous thrombolysis in the treatment of early acute myocardial infarction. Methods: Eighty-six patients with early-stage acute myocardial infarction were enrolled and divided into groups according to whether intravenous thrombolytic therapy was given or not. In the control group, 41 cases were treated with routine therapy without intravenous thrombolysis. In the observation group, 45 cases were treated with the control group, Thrombolytic therapy was used. The success rate of vascular reperfusion, the recanalization time, the fall of ST-T≥50%, the duration of hospitalization and the incidence of acute cardiac events were compared between the two groups. Results: The success rate of vascular reperfusion in the observation group was greater than that of the control group. The recanalization time, the fall of ST-T≥50%, the length of hospital stay were shorter than the control group, the difference was statistically significant (P <0.05) The incidence of cardiac events in acute phase was 17.78%. The incidence of cardiac events in control group was 36.59%. By χ2 test, the incidence of acute cardiac events in observation group was significantly less than that in control group (P <0.05). Conclusion: The clinical effect of intravenous thrombolytic therapy for early acute myocardial infarction is definite, which can relieve and control the disease significantly, reduce the incidence of acute cardiac events, and have high safety and clinical feasibility.